TipRanks
Ascelia Pharma AB (SE:ACE)
:ACE
Sweden Market
ACE
Ascelia Pharma AB
RESEARCH TOOLSreports
Want to see SE:ACE full AI Analyst Report?

Ascelia Pharma AB (ACE) Stock News & Sentiment

3 Followers
Ascelia Pharma Charts New Path for Orviglance After FDA Meeting
Premium
Company Announcements
Ascelia Pharma Charts New Path for Orviglance After FDA Meeting
2d ago
Ascelia Pharma’s Orviglance Study Published in Leading MRI Journal
Premium
Company Announcements
Ascelia Pharma’s Orviglance Study Published in Leading MRI Journal
20d ago
Ascelia Pharma Holds FDA Type A Meeting on Orviglance NDA
Premium
Company Announcements
Ascelia Pharma Holds FDA Type A Meeting on Orviglance NDA
1M ago
Ascelia Pharma Tightens Costs After FDA Setback on Orviglance
Premium
Company Announcements
Ascelia Pharma Tightens Costs After FDA Setback on Orviglance
2M ago
Ascelia Pharma Secures FDA Type A Meeting on Orviglance NDA
Premium
Company Announcements
Ascelia Pharma Secures FDA Type A Meeting on Orviglance NDA
2M ago
Ascelia Pharma Restructures and Cuts Costs to Sharpen Focus on Orviglance
Premium
Company Announcements
Ascelia Pharma Restructures and Cuts Costs to Sharpen Focus on Orviglance
3M ago
Ascelia Pharma Defends Orviglance Data After FDA Complete Response Letter
Premium
Company Announcements
Ascelia Pharma Defends Orviglance Data After FDA Complete Response Letter
3M ago
More SE:ACE News >

ACE News on the Web

Ascelia Pharma Charts New Path for Orviglance After FDA Meeting
TipRanks News
Neutral
Ascelia Pharma Holds FDA Type A Meeting on Orviglance NDA
TipRanks News
Neutral
Ascelia Pharma Tightens Costs After FDA Setback on Orviglance
TipRanks News
Neutral
Ascelia Pharma Receives FDA Complete Response Letter on Orviglance NDA
TipRanks News
Bearish
Ascelia Pharma Bolsters Orviglance Franchise with New Patent Filing
TipRanks News
Bullish
Ascelia Showcases Orviglance MRI Data at ESGAR 2026 Amid FDA Review
TipRanks News
Bullish
Ascelia Pharma Calls 2026 AGM, Proposes No Dividend and New Incentive Plan
TipRanks News
Neutral
Ascelia Pharma’s Orviglance NDA Accepted by FDA as Cash Runway Extends Beyond 2026 Decision
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
SE:ACE
Sector Average
Media Buzz
This Week1 articles
Weekly Average0.5 articles
News Sentiment
This Week50%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SE:ACE’s Media Buzz Sentiment?
1 articles about SE:ACE were published this week. In an average week, 0.5 articles are published.
    What is SE:ACE’s weekly average amount of articles?
    In an average week, 0.5 articles about SE:ACE are published.
      What is SE:ACE’s News Sentiment?
      50% of articles about SE:ACE were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        IQVIQVIA Holdings
        GILDGilead Sciences
        ABBVAbbVie
        VRTXVertex Pharmaceuticals
        NVSNovartis
        Showing the stocks with the most bullish news sentiment over the past week